Arvinas (ARVN) Ownership - Who owns Arvinas?

Industry: @Biotechnology
16 days until earnings call

Profile

Industry
Biotechnology
Address
395 Winchester Avenue
Phone
+1 203 535-1456
Employees
445
Web
https://www.arvinas.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.95B
P/E Ratio
N/A
Total Cash
1.17B
Projected Growth
N/A
Total Debt
2.6M
Revenue
71.3M
Risk (Beta)
1.90
Dividend Yield
N/A
Total Cash/Share
17.09
Total Debt/Equity
N/A
Revenue/Share
1.19 USD as % of share price

Fundamentals

ARVN
Capitalization
1.95B
P/E Ratio
N/A
Risk (Beta)
1.90
Dividend Yield
N/A
Total Cash
1.17B
Total Cash/Share
17.09
Total Debt
2.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.19%
Revenue
71.3M
ROE
N/A
Book Value
610M
P/B Ratio
3.20
Cash Flow
N/A
Earnings
-6.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
4.94
Current Revenue Per Employee
56853.93
Dividends Per Share - Security
N/A
EBITDA
-390.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.71
Shares Held By Institutions
4.76B
Shares Outstanding - Current
68.4M
Total Liabilities
603M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-30.709
View a ticker or compare two or three
ARVN
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapies to degrade disease-causing proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
395 Winchester Avenue
Phone
+1 203 535-1456
Employees
445
Web
https://www.arvinas.com